22157.jpg
Extensive Stage Small Cell Lung Cancer Global Market Report 2022: Next-Generation Sequencing is Helping in Identifying New Molecular Targets
December 14, 2022 08:03 ET | Research and Markets
Dublin, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The "Extensive Stage Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast,...
Qu Biologics Enrolls First Two Participants in Phase 2a Clinical Trial for Lung Cancer
February 04, 2015 10:05 ET | Qu Biologics;BC Cancer Agency
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 4, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...